Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
-
Darden Restaurants Reports Fiscal 2025 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2025 Financial Outlook
-
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
-
Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Inf
-
Mary's Gone Crackers Launches at SaveMart and Lucky Stores, Expanding Retail Presence for Holiday Entertaining
-
Bitflow and Pontis Launch First Bitcoin Runes AMM on Bitcoin L2 Stacks, Enhancing Bitcoin Asset Trading
-
TAFE Urges AGCO to Address Critical Questions Regarding its Strategic Priorities During 2024 Analyst Day
-
Largo and Stryten Energy to Form Storion Energy for the Manufacture of Vanadium Electrolyte and Battery Components for Long Duration Energy Storage
-
Dark Genome Biotech HERVolution Therapeutics Announces $11.7M Series A to Advance Treatments for Cancer & Diseases of Aging
-
Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
B2BINPAY Unveils Redesign, Highlighting Continued Growth and Innovation
-
Stryten Energy and Largo Launch Long-Duration Energy Storage Company
-
Aeva to Showcase New and Existing Automotive Partners and Introduce New 4D LiDAR for Automated Driving at CES 2025
-
Aiwyn Secures $113M in Funding from KKR and Bessemer Venture Partners to Revolutionize Firm Operations and Tax Technology for Leading CPA Firms
-
Siyata Mobile Set to Unveil Pivotal Corporate Milestone
-
CareTrust REIT Doubles Size of Unsecured Revolver to $1.2 Billion; Announces Agency Upgrade of Bond to Investment Grade; Updates Investment Pipeline
-
Starwood Property Trust Completes Capital Markets Transactions
-
Quill and Canadian Business Launch The Moment Podcast, Spotlighting Canada’s Boldest Entrepreneurs
-
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
-
Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity
-
Verde Clean Fuels, Inc. Announces $50 Million Equity Investment by Cottonmouth Ventures, LLC, a Wholly-Owned Subsidiary of Diamondback Energy, Inc.
-
GenBio AI Releases Phase 1 of World's First Digital Organism to Transform Medical Research
-
Dovenmuehle Earns FHA Tier 1 Rating from HUD’s Tier Ranking System (TRS) II Scorecard
-
KKR Releases 2025 Global Macro Outlook
-
Superior Plus to Host Investor Day on April 2, 2025
-
Darmiyan Enters Medicare GUIDE Program Through Partnership with Five Star Home Health Care, CareBrains, and Brain Watch Coalition
-
MindMed to Be Added to the Nasdaq Biotechnology Index
-
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
-
Explorance Named Gold Winner for AI In Education Award by QS Reimagine Education Awards
-
IAS Announces Exclusive First-to-Market Partnership with Kwai for Business to Provide Content-Level Brand Safety and Suitability Measurement for Advertisers
-
Laser Photonics Wins Dual Order From Phillips 66
-
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
-
Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
-
Luka Dončić to Launch the Luka Dončić Foundation, Dedicated to Improving Youth Sports
-
Viad Corp to Relaunch as Pursuit and Trade on NYSE as PRSU
-
Kinaxis Announces $40,000 Academic Award to Empower the Next Generation of Supply Chain Innovators
-
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Arbor Biotechnologies Announces FDA Acceptance of IND Application for ABO-101 for the Treatment of Primary Hyperoxaluria Type 1
-
ProPetro Announces Contract for a 4th FORCE® Electric Hydraulic Fracturing Fleet
-
NMD Pharma Announces Publication of Phase 1 Clinical Trial Data Evaluating NMD670 in Healthy Volunteers in the Journal Clinical Pharmacology & Therapeutics
-
NewGen Engages OSL to Execute Strategic Investment in Digital Assets
-
AleAnna Announces Signing of Gas Sale Contract with Shell Energy Europe
-
PyroGenesis Announces Debt-to-Equity Conversion of Client Receivable
-
Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept Results
-
Climb Bio to be Added to the Nasdaq Biotechnology Index
-
FactSet Reports Results for First Quarter 2025
-
Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025
-
Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights
-
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody
-
OTC Markets Group Welcomes Metaplanet Inc. to OTCQX


